Neurocognitive Impairment in Long COVID: A Systematic Review.

Publication date: Jan 21, 2025

Although Coronavirus disease 2019 (COVID-19) is primarily a respiratory infectious disease, it has also been associated with a wide range of other clinical manifestations. It is widely accepted in the scientific community that many patients after recovery continue to experience COVID-19-related symptoms, including cognitive impairment. The aim of this systematic review was to investigate the cognitive profile of patients with long-COVID syndrome. A systematic search of empirical studies was conducted through the PubMed/Medline and Scopus electronic databases. Cross-sectional and longitudinal studies published between 2020 and 2023 were included. Of the 516 studies assessed for eligibility, 36 studies met the inclusion criteria. All included studies support the presence of persistent cognitive changes after COVID-19 disease. Executive function, memory, attention, and processing speed appear to be the cognitive domains that are predominantly associated with long-COVID syndrome, whereas language is an area that has not been sufficiently investigated. In this review, the high frequency of cognitive impairment after COVID-19 is evident. If we consider that cognitive functioning affects our ability to live independently and is a key determinant of our quality of life, it is imperative to precisely define those factors that may induce cognitive impairment in COVID-19 survivors, with the ultimate goal of early diagnosis of cognitive changes and, consequently, the development of targeted rehabilitation interventions to address them.

Concepts Keywords
Coronavirus Cognitive Dysfunction
Medline COVID-19
Neurocognitive Humans
Pubmed Language
Systematic Long COVID
Neurocognitive impairment
Post-Acute COVID-19 Syndrome

Semantics

Type Source Name
disease MESH Long COVID
disease MESH Coronavirus disease 2019
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH cognitive impairment
disease MESH syndrome
drug DRUGBANK Methionine
disease IDO quality

Original Article

(Visited 3 times, 1 visits today)